Following intramuscular injection of a novel subunit vaccine containing a TLR4 agonist adjuvant, which immunological outcome is most likely, compared to the same vaccine without adjuvant?

💡 Explanation

The TLR4 agonist acts as an adjuvant, triggering increased co-stimulation and cytokine production. This enhanced immune activation promotes greater germinal center activity and B cell affinity maturation; therefore, a vaccine with adjuvant leads to enhanced B cell affinity maturation rather than reduced response observed without it.

• Why does melanin synthesis increase after UVB exposure?
• If neurons accumulate abnormal protein aggregates like amyloid plaques, which consequence relating to proteasomal degradation becomes significant?
• A novel mRNA vaccine elicits a weak initial antibody response; which adaptation is most likely to enhance long-term protection through increased antibody affinity maturation in germinal centers?
• If the vagus nerve signaling to the stomach is chronically reduced, which consequence follows regarding gastric emptying and nutrient absorption?
• If a patient's cardiac preload suddenly decreases during rapid blood loss, which consequence follows related to cardiovascular hemodynamics?
• If a researcher introduces a novel antigen into a mouse engineered to lack functional B cells, which consequence follows regarding adaptive immunity?